ONEMEDNET CORPORATION Gain (Loss) on Disposition of Assets for Financial Service Operations
ONEMEDNET CORPORATION (ONMD) reported Gain (Loss) on Disposition of Assets for Financial Service Operations of -$46.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnSalesOfAssets · last filed 2026-08-14
- ONEMEDNET CORPORATION gain (loss) on disposition of assets for financial service operations for the quarter ending 2026-06-30 was -$46.00K, a 114.65% decline year-over-year.
- ONEMEDNET CORPORATION gain (loss) on disposition of assets for financial service operations for the quarter ending 2026-03-31 was -$188.00K, a 135.40% decline year-over-year.
- ONEMEDNET CORPORATION gain (loss) on disposition of assets for financial service operations for the quarter ending 2025-12-31 was $23.00K, a 86.55% decline year-over-year.
- ONEMEDNET CORPORATION gain (loss) on disposition of assets for financial service operations for the quarter ending 2025-09-30 was $54.00K.
| Period end | Gain (Loss) on Disposition of Assets for Financial Service Operations 3 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 6 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 9 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$46.00K 10-Q · filed 2026-08-14 | -$234.00K 10-Q · filed 2026-08-14 | -$211.00K derived: sum of 3 quarters · filed 2026-08-14 | -$157.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$188.00K S-1/A · filed 2026-07-08 | -$165.00K derived: sum of 2 quarters · filed 2026-07-08 | -$111.00K derived: sum of 3 quarters · filed 2026-07-08 | $203.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $23.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $77.00K derived: sum of 2 quarters · filed 2026-07-08 | $391.00K derived: sum of 3 quarters · filed 2026-08-14 | $922.00K S-1/A · filed 2026-07-08 |
| 2025-09-30 | $54.00K 10-Q · filed 2025-11-14 | $368.00K derived: sum of 2 quarters · filed 2026-08-14 | $899.00K 10-Q · filed 2025-11-14 | $1.07M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $314.00K 10-Q · filed 2026-08-14 | $844.00K 10-Q · filed 2026-08-14 | $1.02M derived: sum of 3 quarters · filed 2026-08-14 | $965.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $531.00K S-1/A · filed 2026-07-08 | $702.00K derived: sum of 2 quarters · filed 2026-07-08 | $651.00K derived: sum of 3 quarters · filed 2026-07-08 | |
| 2024-12-31 | $171.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $120.00K derived: sum of 2 quarters · filed 2026-07-08 | $120.00K S-1/A · filed 2026-07-08 | |
| 2024-09-30 | -$51.00K 10-Q · filed 2025-11-14 | -$51.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |